ArticleFrontiers in oncology2025

Serial TIL infusions and PD-1 blockade drive long-term clonal persistence in prostate cancer.

Lucas C M Arruda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.